Cargando…

Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial

BACKGROUND: Breath analysis is a burgeoning field, with interest in volatile organic compounds (VOCs) as a noninvasive diagnostic tool or an outcome measure, but no randomised controlled trials (RCTs) have yet evaluated this technology in a clinical trial longitudinally. In a pilot RCT, our explorat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan, Divya, Keir, Holly R., Richardson, Hollian, Mayhew, David, Boyer, Joseph, van der Schee, Marc P., Allsworth, Max D., Miller, Bruce E., Tal-Singer, Ruth, Chalmers, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488227/ https://www.ncbi.nlm.nih.gov/pubmed/34616836 http://dx.doi.org/10.1183/23120541.00253-2021

Ejemplares similares

CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin
por: Keir, Holly R., et al.
Publicado: (2020)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD
por: Ratiu, Ileana Andreea, et al.
Publicado: (2020)

The microbiome in bronchiectasis
por: Richardson, Hollian, et al.
Publicado: (2019)

Breath Biopsy(®) to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection
por: Ferrandino, Giuseppe, et al.
Publicado: (2023)

Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD
por: Lonergan, Mike, et al.
Publicado: (2020)

Short-Term Intra-Subject Variation in Exhaled Volatile Organic Compounds (VOCs) in COPD Patients and Healthy Controls and Its Effect on Disease Classification
por: Phillips, Christopher, et al.
Publicado: (2014)

Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity
por: Finamore, Panaiotis, et al.
Publicado: (2018)

Clinical use of exhaled biomarkers in COPD
por: O’Reilly, Philip, et al.
Publicado: (2007)

Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound—Toward Improved Detection of Liver Impairment
por: Ferrandino, Giuseppe, et al.
Publicado: (2020)

Exhaled volatile organic compounds for diagnosis of hepatocellular carcinoma
por: Sukaram, Thanikan, et al.
Publicado: (2022)

Exhaled volatile organic compounds for diagnosis and monitoring of asthma
por: Savito, Luisa, et al.
Publicado: (2023)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath
por: Chen, Xing, et al.
Publicado: (2017)

Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry
por: Bikov, Andras, et al.
Publicado: (2013)

Reproducibility of exhaled biomarkers in COPD—the road less traveled
por: Horvath, Ildiko
Publicado: (2007)

Repeatability of exhaled nitric oxide measurements in patients with COPD
por: Rouhos, Annamari, et al.
Publicado: (2011)

The sputum microbiome is distinct between COPD and health, independent of smoking history
por: Haldar, Koirobi, et al.
Publicado: (2020)

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort
por: Dickens, Jennifer A, et al.
Publicado: (2011)

Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer
por: Oguma, Tsuyoshi, et al.
Publicado: (2017)

Exhaled Volatile Organic Compounds for Identifying Patients With Chronic Pulmonary Aspergillosis
por: Li, Zheng-Tu, et al.
Publicado: (2021)

Volatile Markers for Cancer in Exhaled Breath—Could They Be the Signature of the Gut Microbiota?
por: Bhandari, Manohar Prasad, et al.
Publicado: (2023)

Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities
por: Malerba, Mario, et al.
Publicado: (2014)

Exhaled nitric oxide, eosinophils and current smoking in COPD patients
por: Higham, Andrew, et al.
Publicado: (2023)

The volatile microbiome
por: Weinstock, George M
Publicado: (2011)

Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016)

Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy
por: Keir, Holly R., et al.
Publicado: (2022)

Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia
por: Schnabel, Ronny, et al.
Publicado: (2015)

Evaluation of Bio-VOC Sampler for Analysis of Volatile Organic Compounds in Exhaled Breath
por: Kwak, Jae, et al.
Publicado: (2014)

Limited clinical value of exhaled volatile organic compound measurements in childhood asthma
por: Fuglsbjerg, Maria G., et al.
Publicado: (2018)

Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease
por: Obermeier, Juliane, et al.
Publicado: (2017)

Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosis
por: Chen, Dapeng, et al.
Publicado: (2022)

Relationship between lung function and exhaled volatile organic compounds in healthy infants
por: Sola‐Martínez, Rosa A., et al.
Publicado: (2022)

Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD
por: Corhay, Jean Louis, et al.
Publicado: (2014)

Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
por: Turner, Steve W., et al.
Publicado: (2019)

The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients
por: Principe, Stefania, et al.
Publicado: (2021)

Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate
por: Maniscalco, Mauro, et al.
Publicado: (2022)

Limonene in exhaled breath is elevated in hepatic encephalopathy
por: O’Hara, M E, et al.
Publicado: (2016)

Recent advances in measuring exhaled breath and estimating exposure and body burden for volatile organic compounds (VOCs).
por: Wallace, L A, et al.
Publicado: (1995)

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_j9tqft8eklid4fvforbpiq1sqc